Follow
Katrin I. Tiffner
Katrin I. Tiffner
Verified email at joanneum.at
Title
Cited by
Cited by
Year
Open flow microperfusion as a dermal pharmacokinetic approach to evaluate topical bioequivalence
M Bodenlenz, KI Tiffner, R Raml, T Augustin, C Dragatin, T Birngruber, ...
Clinical pharmacokinetics 56, 91-98, 2017
962017
A comprehensive approach to qualify and validate the essential parameters of an in vitro release test (IVRT) method for acyclovir cream, 5%
KI Tiffner, I Kanfer, T Augustin, R Raml, SG Raney, F Sinner
International journal of pharmaceutics 535 (1-2), 217-227, 2018
522018
Secukinumab distributes into dermal interstitial fluid of psoriasis patients as demonstrated by open flow microperfusion.
C Dragatin, F Polus, M Bodenlenz, C Calonder, B Aigner, KI Tiffner, ...
Experimental dermatology 25 (2), 2016
512016
A novel human ex-vivo burn model and the local cooling effect of a bacterial nanocellulose-based wound dressing
JCJ Holzer, K Tiffner, S Kainz, P Reisenegger, IB de Mattos, M Funk, ...
Burns 46 (8), 1924-1932, 2020
502020
Open flow microperfusion: An alternative method to microdialysis?
T Pieber, T Birngruber, M Bodenlenz, C Höfferer, S Mautner, K Tiffner, ...
Microdialysis in Drug Development, 283-302, 2013
232013
Variability of skin pharmacokinetic data: insights from a topical bioequivalence study using dermal open flow microperfusion
M Bodenlenz, T Augustin, T Birngruber, KI Tiffner, B Boulgaropoulos, ...
Pharmaceutical Research 37, 1-11, 2020
162020
Quantification of basal insulin peglispro and human insulin in adipose tissue interstitial fluid by open-flow microperfusion
K Tiffner, B Boulgaropoulos, C Höfferer, T Birngruber, N Porksen, ...
Diabetes Technology & Therapeutics 19 (5), 305-314, 2017
152017
Assessment of skin permeability to topically applied drugs by skin impedance and admittance
S Schwingenschuh, H Scharfetter, ØG Martinsen, B Boulgaropoulos, ...
Physiological measurement 38 (11), N138, 2017
132017
Comparative in vitro release testing (IVRT) of acyclovir products
KI Tiffner, I Kanfer, T Augustin, R Raml, SG Raney, F Sinner
International Journal of Pharmaceutics 609, 121186, 2021
72021
Dermal Open Flow Microperfusion for PK-based Clinical Bioequivalence Studies of Topical Drug Products
F Sinner, T Birngruber, K Tiffner, SI Mautner
Frontiers in Pharmacology, 4852, 2022
3*2022
The anti IL-17A IgG1 antibody distributes in dermal interstitial fluid as demonstrated by using dermal open flow microperfusion after a single 300 mg subcutaneous …
G Bruin, C Dragatin, B Aigner, F Polus, C Calonder, C Froeliger, K Tiffner, ...
JOURNAL OF INVESTIGATIVE DERMATOLOGY 134, S18-S18, 2014
32014
Skin impedance measurements support ex-vivo penetration studies for topical applied drugs
S Schwingenschuh, M Hajnsek, H Scharfetter, ØG Martinsen, K Tiffner, ...
Biomedical Engineering/Biomedizinische Technik 58 (SI-1-Track-S …, 2013
32013
Bioequivalence of Topical Products in Excised Human Skin Assessed with dermal Open Flow Microperfusion (dOFM)
K Tiffner, M Bodenlenz, D Schimek, P Reisenegger, E Rantou, R Raml, ...
Poster presented at: PPP–Perspectives in Percutaneous Penetration. 16th …, 2018
22018
365 A human ex vivo burn model–its characterization and use for preclinical testing of innovative wound dressings
E Hofmann, JC Holzer-Geißler, K Tiffner, A Eberl, T Birngruber, M Funk, ...
Journal of Investigative Dermatology 141 (10), S212, 2021
12021
344 The Cooling Effect of a Bacterial Nanocellulose-Based Wound Dressing on a Burn Injury
JC Holzer, K Tiffner, S Kainz, P Reisenegger, A Tuca, M Funk, ...
Journal of Burn Care & Research 40 (Supplement_1), S149-S149, 2019
12019
Secukinumab, a novel anti-IL-17A antibody, can be quantified in skin after a single dose by dermal open flow microperfusion (dOFM)
G Bruin, C Dragatin, B Aigner, F Polus, C Calonder, C Froeliger, K Tiffner, ...
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT 12, 15-15, 2014
12014
Characterization of Inflammatory Mediators and Metabolome in Interstitial Fluid Collected with Dermal Open Flow Microperfusion before and at the End of Dupilumab Treatment in …
F Monedeiro, B Ehall, K Tiffner, A Eberl, E Svehlikova, B Prietl, V Pfeifer, ...
Journal of Proteome Research, 2024
2024
Cutaneous Pharmacokinetics-Based Bioequivalence: A Clinical Dermal Open Flow Microperfusion Verification Study Using Lidocaine and Prilocaine Combination Topical Products
KI Tiffner, T Ramezanli, B Boulgaropoulos, T Birngruber, M Bodenlenz, ...
European Journal of Pharmaceutical Sciences, 106827, 2024
2024
120 Interstitial fluid metabolomics shows dupilumab effects in the treatment of atopic dermatitis
F Monedeiro, B Ehall, EM Prugger, E Zügner, E Svehlikova, T Pieber, ...
Journal of Investigative Dermatology 143 (11), S352, 2023
2023
96 Dermal open flow microperfusion (dOFM) to monitor local tissue response after dupilumab treatment in lesional and non-lesional skin of atopic dermatitis patients
K Tiffner, B Ehall, A Eberl, M Bodenlenz, T Pircher, T Birngruber, F Sinner, ...
Journal of Investigative Dermatology 143 (11), S348, 2023
2023
The system can't perform the operation now. Try again later.
Articles 1–20